Stock info West Pharmaceutical Services | Filter  Basic-Info

West Pharmaceutical Services

The past year was a profitable year West Pharmaceutical Services investors

Over the period from December 2015 till December 2016 the stock gained around 38 percent. Over the period from December 2011 till December 2016 the stock rose on average 370 percent. West Pharmaceutical Services's revenues between 2011 and 2015 were relatively stable and moved between 1,27 billion dollars and 1,4 billion dollars. West Pharmaceutical Services's net incomes between 2011 and 2015 were very volatile through the time and moved between 69,2 million dollars and 89,8 million dollars.

West Pharmaceutical Services is active in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

Over the past 5 years the American company paid out dividends. West Pharmaceutical Services's dividend return over the period 2011 - 2015 was around 1,98 percent per year.

Healthy financed: not so much debt West Pharmaceutical Services

At the end of 2015 the American company had a balance sheet of around 1,7 billion dollars. 671,2 million dollars (39,6 percent of the total balance sheet) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 40. So the stock' value was 40 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 4,22 billion dollars. At the end of 2015 the American company had around 72 million stocks listed.

All West Pharmaceutical Services's financial reports are available here. More information about West Pharmaceutical Services can be found it's website. .